世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

フローサイトメトリ(フロー細胞分析)市場:技術毎(細胞、ビーズ)、製品毎(アナライザ、ソータ、試薬・消耗品、ソフトウェア)、エンドユーザ毎(学術、研究所、病院、臨床検査、医薬・バイオ技術)、用途毎、地域毎 - 2023年までの世界市場予測

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents & Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Labs, Pharma-Biotech), Application, and Region - Global Forecast to 2023

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2019年1月US$5,650
シングルユーザライセンス
234 219

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)のフローサイトメトリ(フロー細胞分析)市場に関する調査レポートです。

“The global flow cytometry market is projected to grow at a CAGR of 8.1%.”

The global flow cytometry market is projected to reach USD 5.4 billion by 2023 from USD 3.7 billion in 2018, growing at a CAGR of 8.1% from 2018 to 2023. The key factors driving the growth of this market include technological advancements in flow cytometers, the increasing adoption of flow cytometry in research and clinical trials, growing focus on immunology and immuno-oncology research, high incidence and prevalence of target diseases, and the availability of novel products.

“The bead-based technology segment is expected to grow at the fastest rate during the forecast period.”

By technology, the flow cytometry market is classified into cell-based and bead-based technology. In 2018, the cell-based technology segment accounted for the largest share of the market. However, the bead-based technology segment is expected to grow at the highest CAGR during the forecast period. The growth of the bead-based flow cytometry segment can be attributed to the procedural advantages offered by this technology over other cell-based technology, such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed.
 
“The reagents and consumables product segment is expected to grow at the highest CAGR during 2018-2023.”

On the basis of product and service, the flow cytometry market is categorized into reagents and consumables; instruments; services; software; and accessories. The reagents and consumables segment is expected to witness the highest growth during the forecast period due to the development and commercialization of high-quality application-specific reagents and assays and continuous requirement of flow cytometry reagents by end users (due to the increasing number of flow cytometry-based research activities) are expected to drive the growth of the reagents and consumables market in the coming years.

“Asia Pacific to witness the highest growth during the forecast period (2018–2023)”

North America is expected to hold the largest share of the global flow cytometry market in 2018 followed by Europe. However, the Asia Pacific is expected to grow at the fastest rate during the forecast period. The increasing participation of China, India, Japan, and South Korea in flow cytometry-based research; expansion of research infrastructure in the region; and public-private finding aimed towards boosting advance research practices are the key factors responsible for the growth of this market in the Asia Pacific.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1–33%, Tier 2–46%, and Tier 3–21%
• By Designation: C-level–26%, Director-level–20%, and Others–54%
• By Region: North America–33%, Europe–29%, APAC–24%, and RoW–14%

The major players in the market include Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US), and Apogee Flow Systems Ltd. (UK).

Research Coverage

This report studies the flow cytometry market based on technology, product and service, application, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the flow cytometry market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
 



目次

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY USED FOR THE STUDY 26
1.5 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 28
2.1.2.1 Key data from primary sources 29
2.1.2.2 Breakdown of primaries 30
2.2 MARKET ESTIMATION METHODOLOGY 30
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 31
2.2.2 USAGE-BASED MARKET ESTIMATION 32
2.2.3 PRIMARY RESEARCH VALIDATION 33
2.3 DATA TRIANGULATION METHODOLOGY 33
2.4 RESEARCH ASSUMPTIONS 35
2.5 RESEARCH LIMITATIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 41
4.1 FLOW CYTOMETRY: MARKET OVERVIEW 41
4.2 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 42
4.3 FLOW CYTOMETRY MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 43
4.4 FLOW CYTOMETRY MARKET, BY END USER, 2018 VS. 2023 43
4.5 GEOGRAPHICAL SNAPSHOT OF THE FLOW CYTOMETRY MARKET 44

5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DYNAMICS 45
5.2.1 DRIVERS 46
5.2.1.1 Technological advancements 46
5.2.1.2 Increasing adoption of flow cytometry techniques in research and academia 48
5.2.1.3 Growing public-private initiatives in the field of immunology and immuno-oncology researches 49
5.2.1.4 Rising global incidence and prevalence of HIV/AIDS and cancer 50
5.2.1.5 Increased availability of application-specific products 51
5.2.2 RESTRAINTS 52
5.2.2.1 Significant product costs 52
5.2.2.2 Dearth of well-trained and skilled professionals 53
5.2.3 OPPORTUNITIES 53
5.2.3.1 Growing market presence in emerging countries 53
5.2.3.2 Evolving pipeline for stem cell research 54
5.2.3.3 Adoption of recombinant DNA technology for antibody production 54
5.2.3.4 Advent of tandem flow cytometry technologies 55
5.2.4 CHALLENGES 55
5.2.4.1 Inadequate research infrastructure across emerging countries 55
5.2.4.2 Complexities related to reagent development 55
5.2.4.3 Limited purchasing power of majority of end users in emerging countries 55
5.3 REGULATORY CHALLENGES 56
5.3.1 STRINGENT FDA REQUIREMENTS 56
5.3.2 STRINGENT ANALYTE-SPECIFIC REAGENT (ASR) RULE 56
5.3.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS 56
5.3.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST (LDT) GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS 56
5.3.5 GREATER GLOBAL RECOGNITION FOR IVD–CE MARK APPROVALS 57
5.4 U.S. REIMBURSEMENT SCENARIO 57
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 58
6.1 INTRODUCTION 59
6.2 CELL-BASED FLOW CYTOMETRY 60
6.2.1 CELL-BASED TECHNOLOGIES TO DOMINATE THE GLOBAL MARKET TILL 2023 60
6.3 BEAD-BASED FLOW CYTOMETRY 61
6.3.1 PROCEDURAL ADVANTAGES TO DRIVE THE MARKET GROWTH FOR BEAD-BASED FLOW CYTOMETRY SEGMENT 61

7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 63
7.1 INTRODUCTION 64
7.2 REAGENTS AND CONSUMABLES 65
7.2.1 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET SPLIT,
BY APPLICATION 65
7.2.2 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET SPLIT,
BY RESEARCH APPLICATION 66
7.2.3 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET SPLIT,
BY CLINICAL APPLICATION 66
7.2.4 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET SPLIT,
BY END USER 67
7.3 FLOW CYTOMETRY INSTRUMENTS 68
7.3.1 FLOW CYTOMETRY INSTRUMENTS MARKET SPLIT, BY APPLICATION 69
7.3.2 FLOW CYTOMETRY INSTRUMENTS MARKET SPLIT, BY RESEARCH APPLICATION 69
7.3.3 FLOW CYTOMETRY INSTRUMENTS MARKET SPLIT, BY CLINICAL APPLICATION 70
7.3.4 FLOW CYTOMETRY INSTRUMENTS MARKET SPLIT, BY END USER 70
7.3.5 CELL ANALYZERS 72
7.3.5.1 Flow cytometry based cell analyzers market split, by application 73
7.3.5.2 Flow cytometry based cell analyzers market split, by research application 73
7.3.5.3 Flow cytometry based cell analyzers market split, by clinical application 74
7.3.5.4 Flow cytometry based cell analyzers market split, by end user 74
7.3.5.5 High-range cell analyzers 76
7.3.5.5.1 High-range cell analyzers account for the largest share of the cell analyzers market 76
7.3.5.6 Mid-range cell analyzers 77
7.3.5.6.1 Wide availability of compact and high-performance analyzers in this price range support market growth 77
7.3.5.7 Low-range cell analyzers 77
7.3.5.7.1 Low-range analyzers find significant adoption among price-sensitive end users 77
7.3.6 CELL SORTERS 78
7.3.6.1 Flow cytometry based cell sorters market split, by application 79
7.3.6.2 Flow cytometry based cell sorters market split, by research application 80
7.3.6.3 Flow cytometry based cell sorters market split, by clinical application 80
7.3.6.4 Flow cytometry based cell sorters market split, by end user 81
7.3.6.5 High-range cell sorters 82
7.3.6.5.1 High-range cell sorters dominate the market 82
7.3.6.6 Mid-range cell sorters 83
7.3.6.6.1 Product launches and a balance between efficiency and costs have enabled the growth of this market segment 83

7.3.6.7 Low-range cell sorters 84
7.3.6.7.1 Increasing commercialization of affordable products has driven adoption of low-range cell sorters 84
7.4 SERVICES 85
7.4.1 FLOW CYTOMETRY SERVICES MARKET SPLIT, BY APPLICATION 85
7.4.2 FLOW CYTOMETRY SERVICES MARKET SPLIT, BY RESEARCH APPLICATION 86
7.4.3 FLOW CYTOMETRY SERVICES MARKET SPLIT, BY CLINICAL APPLICATION 86
7.4.4 FLOW CYTOMETRY SERVICES MARKET SPLIT, BY END USER 87
7.5 SOFTWARE 88
7.5.1 FLOW CYTOMETRY SOFTWARE MARKET SPLIT, BY APPLICATION 88
7.5.2 FLOW CYTOMETRY SOFTWARE MARKET SPLIT, BY RESEARCH APPLICATION 89
7.5.3 FLOW CYTOMETRY SOFTWARE MARKET SPLIT, BY CLINICAL APPLICATION 89
7.5.4 FLOW CYTOMETRY SOFTWARE MARKET SPLIT, BY END USER 90
7.6 ACCESSORIES 91
7.6.1 FLOW CYTOMETRY ACCESSORIES MARKET SPLIT, BY APPLICATION 91
7.6.2 FLOW CYTOMETRY ACCESSORIES MARKET SPLIT, BY RESEARCH APPLICATION 92
7.6.3 FLOW CYTOMETRY ACCESSORIES MARKET SPLIT, BY CLINICAL APPLICATION 92
7.6.4 FLOW CYTOMETRY ACCESSORIES MARKET SPLIT, BY END USER 93
8 FLOW CYTOMETRY MARKET, BY APPLICATION 94
8.1 INTRODUCTION 95
8.2 RESEARCH APPLICATIONS 96
8.2.1 PHARMACEUTICALS & BIOTECHNOLOGY 98
8.2.1.1 Drug discovery 99
8.2.1.1.1 Wide usage of flow cytometry in drug discovery is the primary driver of market growth 99
8.2.1.2 Stem cell research 100
8.2.1.2.1 Accuracy and precision of flow cytometry have made it a prominent tool in stem cell research 100
8.2.1.3 In vitro toxicity testing 102
8.2.1.3.1 Need to reduce time and cost of drug development processes will be a key factor driving market growth 102
8.2.2 IMMUNOLOGY 103
8.2.2.1 Flow cytometry plays a vital role in immunology studies 103
8.2.3 CELL SORTING 104
8.2.3.1 The increase in cell-based research activity has boosted growth in this application segment 104
8.2.4 APOPTOSIS 105
8.2.4.1 Flow cytometry techniques are used to identify changes occurring during apoptosis 105
8.2.5 CELL CYCLE ANALYSIS 106
8.2.5.1 Any abnormality in DNA content can be detected using flow cytometry 106

8.2.6 CELL VIABILITY 107
8.2.6.1 Cell viability is a key parameter studied using flow cytometry 107
8.2.7 CELL COUNTING 108
8.2.7.1 Flow cytometry allows for easy differentiation of cells via scattering or staining 108
8.2.8 OTHER RESEARCH APPLICATIONS 109
8.3 CLINICAL APPLICATIONS 109
8.3.1 CANCER 111
8.3.1.1 Cancer applications include determination of tumor malignancy and chromosome enumeration 111
8.3.2 HEMATOLOGY 112
8.3.2.1 Flow cytometry can help identify a wide variety of cell surfaces and cytoplasmic antigens 112
8.3.3 IMMUNODEFICIENCY DISEASES 113
8.3.3.1 Flow cytometry allows for simultaneous, multi-parameter cell analysis 113
8.3.4 ORGAN TRANSPLANTATION 114
8.3.4.1 Use of flow cytometry to reduce organ rejection rates has contributed to market growth 114
8.3.5 OTHER CLINICAL APPLICATIONS 115
8.4 INDUSTRIAL APPLICATIONS 115
8.4.1 WIDE END USER BASE TO DRIVE INDUSTRIAL APPLICATION MARKET GROWTH 115
9 FLOW CYTOMETRY MARKET, BY END USER 117
9.1 INTRODUCTION 118
9.2 ACADEMIC AND RESEARCH INSTITUTES 119
9.2.1 STRENGTHENING RESEARCH PIPELINE AND INDUSTRY-ACADEMIA COLLABORATION TO DRIVE THE MARKET GROWTH 119
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 120
9.3.1 RISING AWARENESS AND DISEASE PREVALENCE HAVE SUSTAINED THE DEMAND FOR FLOW CYTOMETRY 120
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 121
9.4.1 GROWING DRUG DISCOVERY ACTIVITY TO DRIVE MARKET GROWTH 121
10 FLOW CYTOMETRY MARKET, BY REGION 123
10.1 INTRODUCTION 124
10.2 NORTH AMERICA 125
10.2.1 US 129
10.2.1.1 High adoption of advanced flow cytometry products among end users to drive market growth in the US 129
10.2.2 CANADA 132
10.2.2.1 Availability of public and private funding for research activities to boost the demand for flow cytometry products in Canada 132

10.3 EUROPE 134
10.3.1 GERMANY 138
10.3.1.1 Greater outsourcing of clinical diagnostic services to be the key trend in the German flow cytometry market 138
10.3.2 UK 141
10.3.2.1 UK to witness growing acceptance of flow cytometry products for clinical diagnostics 141
10.3.3 FRANCE 143
10.3.3.1 Training and awareness programs by social organizations and key players expected to fuel the adoption of flow cytometry 143
10.3.4 REST OF EUROPE 145
10.4 ASIA PACIFIC 148
10.4.1 JAPAN 151
10.4.1.1 Strong infrastructure and favorable market outlook have sustained Japan’s dominance in the APAC market 151
10.4.2 CHINA 153
10.4.2.1 China accounts for the second-largest share in the APAC market 153
10.4.3 INDIA 155
10.4.3.1 High incidence of HIV/AIDS and cancer to drive the demand for flow cytometry instruments in India 155
10.4.4 REST OF ASIA PACIFIC 158
10.5 LATIN AMERICA 160
10.5.1 BRAZIL 163
10.5.1.1 Brazil dominates the LATAM market for flow cytometry 163
10.5.2 MEXICO 165
10.5.2.1 Free trade agreements will support imports, accessibility to flow cytometry instruments in Mexico 165
10.5.3 REST OF LATIN AMERICA 167
10.6 MIDDLE EAST AND AFRICA 170
10.6.1 LOW DISPOSABLE INCOME AND NEED FOR INFRASTRUCTURAL DEVELOPMENT HINDER MARKET GROWTH 170
11 COMPETITIVE LANDSCAPE 173
11.1 OVERVIEW 173
11.2 GLOBAL MARKET SHARE ANALYSIS (2017) 174
11.3 COMPETITIVE SCENARIO 175
11.3.1 KEY PRODUCT LAUNCHES AND APPROVALS (2015–2018) 175
11.3.2 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2015–2018) 175
11.3.3 KEY ACQUISITIONS (2015–2018) 176
11.3.4 KEY EXPANSIONS (2015–2018) 177
11.4 COMPETITIVE LEADERSHIP MAPPING 177
11.4.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2017) 178
11.4.1.1 VANGUARDS 178
11.4.1.2 INNOVATORS 178
11.4.1.3 DYNAMIC PLAYERS 178
11.4.1.4 EMERGING COMPANIES 178
11.4.2 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2017) 179
11.4.2.1 PROGRESSIVE COMPANIES 179
11.4.2.2 STARTING BLOCKS 179
11.4.2.3 RESPONSIVE COMPANIES 180
11.4.2.4 DYNAMIC COMPANIES 180
12 COMPANY PROFILES 181
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 AGILENT TECHNOLOGIES 181
12.2 APOGEE FLOW SYSTEMS 184
12.3 BECKMAN COULTER (A SUBSIDIARY OF DANAHER) 185
12.4 BECTON, DICKINSON AND COMPANY 188
12.5 BIOMÉRIEUX S.A. 194
12.6 BIO-RAD LABORATORIES 196
12.7 CYTONOME ST 199
12.8 ENZO LIFE SCIENCES (A WHOLLY OWNED SUBSIDIARY OF ENZO BIOCHEM, INC.) 200
12.9 LUMINEX 203
12.10 MERCK KGAA 206
12.11 MILTENYI BIOTEC 212
12.12 SONY BIOTECHNOLOGY (A WHOLLY OWNED SUBSIDIARY OF SONY CORPORATION OF AMERICA) 215
12.13 STRATEDIGM 218
12.14 SYSMEX PARTEC (A SUBSIDIARY OF SYSMEX CORPORATION) 219
12.15 THERMO FISHER SCIENTIFIC 222

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 226
13.1 DISCUSSION GUIDE 226
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 230
13.3 AVAILABLE CUSTOMIZATIONS 232
13.4 RELATED REPORTS 232
13.5 AUTHOR DETAILS 233

 

LIST OF TABLES

TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2017 50
TABLE 2 CANCER INCIDENCE AND PREVALENCE DATA, BY COUNTRY, 2018 51
TABLE 3 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 60
TABLE 4 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2016–2023 (USD MILLION) 61
TABLE 5 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2016–2023 (USD MILLION) 62
TABLE 6 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 64
TABLE 7 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 65
TABLE 8 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET,
BY RESEARCH APPLICATION, 2016–2023 (USD MILLION) 66
TABLE 9 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET,
BY CLINICAL APPLICATION, 2016–2023 (USD MILLION) 66
TABLE 10 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET,
BY END USERS, 2016–2023 (USD MILLION) 67
TABLE 11 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET,
BY REGION, 2016–2023 (USD MILLION) 67
TABLE 12 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 68
TABLE 13 FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT, 2016–2023 (UNITS) 68
TABLE 14 FLOW CYTOMETRY INSTRUMENTS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 69
TABLE 15 FLOW CYTOMETRY INSTRUMENTS MARKET, BY RESEARCH APPLICATION,
2016–2023 (USD MILLION) 69
TABLE 16 FLOW CYTOMETRY INSTRUMENTS MARKET, BY CLINICAL APPLICATION,
2016–2023 (USD MILLION) 70
TABLE 17 FLOW CYTOMETRY INSTRUMENTS MARKET, BY END USERS,
2016–2023 (USD MILLION) 70
TABLE 18 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 71
TABLE 19 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2016–2023 (UNITS) 71
TABLE 20 FLOW CYTOMETRY BASED CELL ANALYZERS MARKET, BY PRICE RANGE,
2016–2023 (USD MILLION) 72
TABLE 21 FLOW CYTOMETRY BASED CELL ANALYZERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 73
TABLE 22 FLOW CYTOMETRY BASED CELL ANALYZERS MARKET, BY RESEARCH APPLICATION, 2016–2023 (USD MILLION) 73
TABLE 23 FLOW CYTOMETRY BASED CELL ANALYZERS MARKET, BY CLINICAL APPLICATION, 2016–2023 (USD MILLION) 74
TABLE 24 FLOW CYTOMETRY BASED CELL ANALYZERS MARKET, BY END USERS,
2016–2023 (USD MILLION) 74
TABLE 25 FLOW CYTOMETRY BASED CELL ANALYZERS MARKET, BY REGION,
2016–2023 (USD MILLION) 75
TABLE 26 FLOW CYTOMETRY BASED CELL ANALYZERS MARKET, BY REGION,
2016–2023 (UNITS) 75
TABLE 27 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2016–2023 (USD MILLION)- 76
TABLE 28 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2016–2023 (USD MILLION) 77
TABLE 29 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2016–2023 (USD MILLION) 78
TABLE 30 FLOW CYTOMETRY BASED CELL SORTERS MARKET, BY PRICE RANGE,
2016–2023 (USD MILLION) 79
TABLE 31 FLOW CYTOMETRY BASED CELL SORTERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 79
TABLE 32 FLOW CYTOMETRY BASED CELL SORTERS MARKET, BY RESEARCH APPLICATION, 2016–2023 (USD MILLION) 80
TABLE 33 FLOW CYTOMETRY BASED CELL SORTERS MARKET, BY CLINICAL APPLICATION, 2016–2023 (USD MILLION) 80
TABLE 34 FLOW CYTOMETRY BASED CELL SORTERS MARKET, BY END USERS,
2016–2023 (USD MILLION) 81
TABLE 35 FLOW CYTOMETRY BASED CELL SORTERS MARKET, BY REGION,
2016–2023 (USD MILLION) 81
TABLE 36 FLOW CYTOMETRY BASED CELL SORTERS MARKET, BY REGION,
2016–2023 (UNITS) 82
TABLE 37 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2016–2023 (USD MILLION) 83
TABLE 38 MID-RANGE CELL SORTERS MARKET, BY REGION, 2016–2023 (USD MILLION) 84
TABLE 39 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2016–2023 (USD MILLION) 84
TABLE 40 FLOW CYTOMETRY SERVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 85
TABLE 41 FLOW CYTOMETRY SERVICES MARKET, BY RESEARCH APPLICATION,
2016–2023 (USD MILLION) 86
TABLE 42 FLOW CYTOMETRY SERVICES MARKET, BY CLINICAL APPLICATION,
2016–2023 (USD MILLION) 86
TABLE 43 FLOW CYTOMETRY SERVICES MARKET, BY END USERS,
2016–2023 (USD MILLION) 87
TABLE 44 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION) 87
TABLE 45 FLOW CYTOMETRY SOFTWARE MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 88
TABLE 46 FLOW CYTOMETRY SOFTWARE MARKET, BY RESEARCH APPLICATION,
2016–2023 (USD MILLION) 89
TABLE 47 FLOW CYTOMETRY SOFTWARE MARKET, BY CLINICAL APPLICATION,
2016–2023 (USD MILLION) 89
TABLE 48 FLOW CYTOMETRY SOFTWARE MARKET, BY END USERS,
2016–2023 (USD MILLION) 90
TABLE 49 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2016–2023 (USD MILLION) 90
TABLE 50 FLOW CYTOMETRY ACCESSORIES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 91
TABLE 51 FLOW CYTOMETRY ACCESSORIES MARKET, BY RESEARCH APPLICATION,
2016–2023 (USD MILLION) 92
TABLE 52 FLOW CYTOMETRY ACCESSORIES MARKET, BY CLINICAL APPLICATION,
2016–2023 (USD MILLION) 92
TABLE 53 FLOW CYTOMETRY ACCESSORIES MARKET, BY END USERS,
2016–2023 (USD MILLION) 93
TABLE 54 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION,
2016–2023 (USD MILLION) 93
TABLE 55 FLOW CYTOMETRY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 96
TABLE 56 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2016–2023 (USD MILLION) 97
TABLE 57 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 97
TABLE 58 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION) 98
TABLE 59 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 98
TABLE 60 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 100
TABLE 61 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 101
TABLE 62 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 103
TABLE 63 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 104
TABLE 64 FLOW CYTOMETRY MARKET FOR CELL SORTING APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 105
TABLE 65 FLOW CYTOMETRY MARKET FOR APOPTOSIS APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 106
TABLE 66 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 106
TABLE 67 FLOW CYTOMETRY MARKET FOR CELL VIABILITY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 107
TABLE 68 FLOW CYTOMETRY MARKET FOR CELL COUNTING APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 108
TABLE 69 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 109
TABLE 70 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,
2016–2023 (USD MILLION) 110
TABLE 71 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 110
TABLE 72 FLOW CYTOMETRY MARKET FOR CANCER APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 111
TABLE 73 FLOW CYTOMETRY MARKET FOR HEMATOLOGY APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 112
TABLE 74 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 113
TABLE 75 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 114
TABLE 76 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 115
TABLE 77 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 116
TABLE 78 FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 118
TABLE 79 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2016–2023 (USD MILLION) 120
TABLE 80 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 121
TABLE 81 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 122
TABLE 82 FLOW CYTOMETRY MARKET, BY REGION, 2016–2023 (USD MILLION) 124
TABLE 83 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 126
TABLE 84 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 126
TABLE 85 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 127
TABLE 86 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT, 2016–2023 (UNITS) 127
TABLE 87 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 127
TABLE 88 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 128
TABLE 89 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER,
2016–2023 (USD MILLION) 128
TABLE 90 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 130
TABLE 91 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 130
TABLE 92 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 130
TABLE 93 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 131
TABLE 94 US: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 131
TABLE 95 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 132
TABLE 96 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 133
TABLE 97 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 133
TABLE 98 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 133
TABLE 99 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 134
TABLE 100 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 136
TABLE 101 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 136
TABLE 102 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 137
TABLE 103 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (UNITS) 137
TABLE 104 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 137
TABLE 105 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 138
TABLE 106 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 138
TABLE 107 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 139
TABLE 108 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 139
TABLE 109 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 140
TABLE 110 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 140
TABLE 111 GERMANY: FLOW CYTOMETRY MARKET, BY END USER,
2016–2023 (USD MILLION) 140
TABLE 112 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 141
TABLE 113 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 142
TABLE 114 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 142
TABLE 115 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 142
TABLE 116 UK: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 143
TABLE 117 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 144
TABLE 118 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 144
TABLE 119 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 144
TABLE 120 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 145
TABLE 121 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 145
TABLE 122 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 146
TABLE 123 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 146
TABLE 124 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 147
TABLE 125 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 147
TABLE 126 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER,
2016–2023 (USD MILLION) 147
TABLE 127 APAC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 149
TABLE 128 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 149
TABLE 129 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 149
TABLE 130 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (UNITS) 150
TABLE 131 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 150
TABLE 132 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 150
TABLE 133 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER,
2016–2023 (USD MILLION) 151
TABLE 134 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 151
TABLE 135 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 152
TABLE 136 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 152
TABLE 137 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 152
TABLE 138 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 153
TABLE 139 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 154
TABLE 140 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 154
TABLE 141 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 154
TABLE 142 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 155
TABLE 143 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 155
TABLE 144 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 156
TABLE 145 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 156
TABLE 146 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 157
TABLE 147 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 157
TABLE 148 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 157
TABLE 149 ROAPAC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 158
TABLE 150 ROAPAC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 158
TABLE 151 ROAPAC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 159
TABLE 152 ROAPAC: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 159
TABLE 153 ROAPAC: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 160
TABLE 154 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 160
TABLE 155 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 161
TABLE 156 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 161
TABLE 157 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (UNITS) 161
TABLE 158 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 162
TABLE 159 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 162
TABLE 160 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER,
2016–2023 (USD MILLION) 162
TABLE 161 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 163
TABLE 162 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 164
TABLE 163 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 164
TABLE 164 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 164
TABLE 165 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 165
TABLE 166 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 166
TABLE 167 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 166
TABLE 168 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 166
TABLE 169 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 167
TABLE 170 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 167
TABLE 171 ROLA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 168
TABLE 172 ROLA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 168
TABLE 173 ROLA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 168
TABLE 174 ROLA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 169
TABLE 175 ROLA: FLOW CYTOMETRY MARKET, BY END USER, 2016–2023 (USD MILLION) 169
TABLE 176 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 170
TABLE 177 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 171
TABLE 178 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET,
BY PRODUCT, 2016–2023 (UNITS) 171
TABLE 179 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 171
TABLE 180 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 172
TABLE 181 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET, BY END USER,
2016–2023 (USD MILLION) 172

 

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 27
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 30
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 31
FIGURE 4 MARKET SIZE ESTIMATION: FLOW CYTOMETRY MARKET 32
FIGURE 5 GLOBAL FLOW CYTOMETRY MARKET: DATA TRIANGULATION 34
FIGURE 6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION) 36
FIGURE 7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD MILLION) 37
FIGURE 8 FLOW CYTOMETRY MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 37
FIGURE 9 FLOW CYTOMETRY MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 38
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE FLOW CYTOMETRY MARKET 39
FIGURE 11 ONGOING TECHNOLOGICAL ADVANCEMENTS AND GREATER ADOPTION AMONG RESEARCHERS & ACADEMIA TO DRIVE THE OVERALL MARKET GROWTH 41
FIGURE 12 REAGENTS AND CONSUMABLES TO ACCOUNT FOR THE LARGEST MARKET SHARE TILL 2023 42
FIGURE 13 RESEARCH APPLICATIONS WILL CONTINUE TO DOMINATE THE GLOBAL FLOW CYTOMETRY MARKET IN 2023 43
FIGURE 14 HOSPITALS AND CLINICAL TESTING LABORATORIES TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2023 43
FIGURE 15 ASIA PACIFIC TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD 44
FIGURE 16 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
FIGURE 17 CELL-BASED FLOW CYTOMETRY SEGMENT WILL CONTINUE TO DOMINATE THE FLOW CYTOMETRY MARKET IN 2023 59
FIGURE 18 REAGENTS AND CONSUMABLES SEGMENT TO DOMINATE THE FLOW CYTOMETRY MARKET IN 2018 64
FIGURE 19 CLINICAL APPLICATIONS POISED TO BE THE FASTEST GROWING SEGMENT DURING THE FORECAST PERIOD 95
FIGURE 20 HOSPITALS & CLINICAL TESTING LABORATORIES TO WITNESS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 118
FIGURE 21 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 125
FIGURE 22 EUROPE: FLOW CYTOMETRY MARKET SNAPSHOT 135
FIGURE 23 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT 148
FIGURE 24 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE FLOW CYTOMETRY MARKET, 2015–2018 173
FIGURE 25 GLOBAL FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY TOP 3 PLAYERS (2017) 174
FIGURE 26 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) 179
FIGURE 27 COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS) 180
FIGURE 28 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017) 181
FIGURE 29 DANAHER: COMPANY SNAPSHOT (2017) 185
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018) 188
FIGURE 31 BIOMÉRIEUX S.A.: COMPANY SNAPSHOT (2017) 194
FIGURE 32 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017) 196
FIGURE 33 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2017) 200
FIGURE 34 LUMINEX: COMPANY SNAPSHOT (2017) 203
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2017) 206
FIGURE 36 SONY CORPORATION: COMPANY SNAPSHOT (2017) 215
FIGURE 37 SYSMEX CORPORATION: COMPANY SNAPSHOT (2017) 219
FIGURE 38 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 223
 

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る